JACKSONVILLE, Fla. – (October 20, 2014) – The American Association of Clinical Endocrinologists (AACE) today unveiled ENDO360, a market research entity comprised of clinical endocrinologists available for market research projects focused on endocrine diseases.
ENDO360 meets the need of organizations that wish to conduct studies solely on endocrine- related diseases including thyroid, diabetes, osteoporosis, hormone deficiencies, obesity and more.
“The creation of ENDO360 will match organizations interested in conducting endocrine market research with AACE members who agreed to participate,” said AACE President, R. Mack Harrell, MD, FACP, FACE, ECNU.
AACE is the largest association of practicing clinical endocrinologists who have undergone special education and training in the practice of clinical endocrinology.
The Endo360 initiative lets organizations reach out to endocrine experts who can provide feedback on marketing project development, implementation and delivery. Prospective partners on this project are seasoned healthcare research companies that have proficiency in physician and payor research.
About the American Association of Clinical Endocrinologists (AACE)
The American Association of Clinical Endocrinologists (AACE) represents more than 6,500 endocrinologists in the United States and abroad. AACE is the largest association of clinical endocrinologists in the world. The majority of AACE members are certified in endocrinology, diabetes and metabolism and concentrate on the treatment of patients with endocrine and metabolic disorders including diabetes, thyroid disorders, osteoporosis, growth hormone deficiency, cholesterol disorders, hypertension and obesity. Visit our site at www.aace.com.